143 related articles for article (PubMed ID: 35501195)
1. Patient-specific severity of von Willebrand factor degradation identifies patients with a left ventricular assist device at high risk for bleeding.
Hennessy-Strahs S; Kang J; Krause E; Dowling RD; Rame JE; Bartoli CR
J Thorac Cardiovasc Surg; 2024 Jan; 167(1):196-204. PubMed ID: 35501195
[TBL] [Abstract][Full Text] [Related]
2. Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis.
Bartoli CR; Zhang DM; Hennessy-Strahs S; Kang J; Restle DJ; Bermudez C; Atluri P; Acker MA
Circ Heart Fail; 2018 Sep; 11(9):e004638. PubMed ID: 30354363
[TBL] [Abstract][Full Text] [Related]
3. Toward a Standard Practice to Quantify von Willebrand Factor Degradation During Left Ventricular Assist Device Support.
Hennessy-Strahs S; Bermudez CA; Acker MA; Bartoli CR
Ann Thorac Surg; 2021 Oct; 112(4):1257-1264. PubMed ID: 33227272
[TBL] [Abstract][Full Text] [Related]
4. Decreased RPM reduces von Willebrand factor degradation with the EVAHEART LVAS: implications for device-specific LVAD management.
Bartoli CR; Kang J; Motomura T
J Card Surg; 2020 Jul; 35(7):1477-1483. PubMed ID: 32652785
[TBL] [Abstract][Full Text] [Related]
5. Association between the severity of acquired von Willebrand syndrome and gastrointestinal bleeding after continuous-flow left ventricular assist device implantation.
Sakatsume K; Saito K; Akiyama M; Sasaki K; Kawatsu S; Takahashi G; Adachi O; Kawamoto S; Horiuchi H; Saiki Y
Eur J Cardiothorac Surg; 2018 Nov; 54(5):841-846. PubMed ID: 29741685
[TBL] [Abstract][Full Text] [Related]
6. Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation.
Kang J; Zhang DM; Restle DJ; Kallel F; Acker MA; Atluri P; Bartoli CR
J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1747-1754.e1. PubMed ID: 26971377
[TBL] [Abstract][Full Text] [Related]
7. Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device.
Meyer AL; Malehsa D; Budde U; Bara C; Haverich A; Strueber M
JACC Heart Fail; 2014 Apr; 2(2):141-5. PubMed ID: 24720921
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of von Willebrand factor profiles after implantation of left ventricular assist device and total artificial heart.
Reich HJ; Morgan J; Arabia F; Czer L; Moriguchi J; Ramzy D; Esmailian F; Lam L; Dunhill J; Volod O
J Thromb Haemost; 2017 Aug; 15(8):1620-1624. PubMed ID: 28586149
[TBL] [Abstract][Full Text] [Related]
9. Bleeding in patients with continuous-flow left ventricular assist devices: acquired von Willebrand disease or antithrombotics?
Consolo F; Marasi A; Della Valle P; Bonora M; Pieri M; Scandroglio AM; Redaelli A; Zangrillo A; D'Angelo A; Pappalardo F
Eur J Cardiothorac Surg; 2022 Jun; 62(1):. PubMed ID: 34718493
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.
Bartoli CR; Kang J; Restle DJ; Zhang DM; Shabahang C; Acker MA; Atluri P
JACC Heart Fail; 2015 Nov; 3(11):860-9. PubMed ID: 26454844
[TBL] [Abstract][Full Text] [Related]
11. Continuous-Flow LVAD Support Causes a Distinct Form of Intestinal Angiodysplasia.
Kang J; Hennessy-Strahs S; Kwiatkowski P; Bermudez CA; Acker MA; Atluri P; McConnell PI; Bartoli CR
Circ Res; 2017 Sep; 121(8):963-969. PubMed ID: 28729354
[TBL] [Abstract][Full Text] [Related]
12. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients.
Crow S; Chen D; Milano C; Thomas W; Joyce L; Piacentino V; Sharma R; Wu J; Arepally G; Bowles D; Rogers J; Villamizar-Ortiz N
Ann Thorac Surg; 2010 Oct; 90(4):1263-9; discussion 1269. PubMed ID: 20868825
[TBL] [Abstract][Full Text] [Related]
13. von Willebrand Factor Abnormalities and Heyde Syndrome in Dysfunctional Heart Valve Prostheses.
Blackshear JL; McRee CW; Safford RE; Pollak PM; Stark ME; Thomas CS; Rivera CE; Wysokinska EM; Chen D
JAMA Cardiol; 2016 May; 1(2):198-204. PubMed ID: 27437891
[TBL] [Abstract][Full Text] [Related]
14. Effects of HeartWare ventricular assist device on the von Willebrand factor: results of an academic Belgian center.
Esmaeilzadeh F; Wauters A; Wijns W; Argacha JF; van de Borne P
BMC Cardiovasc Disord; 2016 Aug; 16(1):155. PubMed ID: 27485105
[TBL] [Abstract][Full Text] [Related]
15. Preclinical Models for Translational Investigations of Left Ventricular Assist Device-Associated von Willebrand Factor Degradation.
Restle DJ; Zhang DM; Hung G; Howard JL; Kallel F; Acker MA; Atluri P; Bartoli CR
Artif Organs; 2015 Jul; 39(7):569-75. PubMed ID: 25810063
[TBL] [Abstract][Full Text] [Related]
16. Detection of acquired von Willebrand syndrome after ventricular assist device by total thrombus-formation analysis system.
Takashio S; Kaikita K; Nishi M; Morioka M; Higo T; Shiose A; Doman T; Horiuchi H; Fukui T; Tsujita K
ESC Heart Fail; 2020 Oct; 7(5):3235-3239. PubMed ID: 32700467
[TBL] [Abstract][Full Text] [Related]
17. Acquired von Willebrand syndrome in paediatric patients during mechanical circulatory support.
Kubicki R; Stiller B; Kroll J; Siepe M; Beyersdorf F; Benk C; Höhn R; Grohmann J; Fleck T; Zieger B
Eur J Cardiothorac Surg; 2019 Jun; 55(6):1194-1201. PubMed ID: 30590475
[TBL] [Abstract][Full Text] [Related]
18. Left Ventricular Assist Device Design Reduces von Willebrand Factor Degradation: A Comparative Study Between the HeartMate II and the EVAHEART Left Ventricular Assist System.
Bartoli CR; Kang J; Zhang D; Howard J; Acker M; Atluri P; Motomura T
Ann Thorac Surg; 2017 Apr; 103(4):1239-1244. PubMed ID: 27717422
[TBL] [Abstract][Full Text] [Related]
19. Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage.
Bartoli CR; Restle DJ; Zhang DM; Acker MA; Atluri P
J Thorac Cardiovasc Surg; 2015 Jan; 149(1):281-9. PubMed ID: 25439775
[TBL] [Abstract][Full Text] [Related]
20. Acquired von Willebrand factor deficiency is reduced in HeartMate 3 patients†.
Klaeske K; Dieterlen MT; Scholz U; Lehmann S; Garbade J; Fischer J; Jawad K; Borger MA; Meyer A
Eur J Cardiothorac Surg; 2019 Sep; 56(3):444-450. PubMed ID: 30815698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
